Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00661_DB00976_nanopub.RAOrIQJw8JmCLZJZzA1mu6PoE5F-1dBi1WFMaagleOjYQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00661_DB00976 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00661_DB00976 label "DDI between Verapamil and Telithromycin - Telithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vinblastine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Telithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00661_DB00976]" assertion.
- drugbank_resource:DB00661_DB00976 identifier "drugbank_resource:DB00661_DB00976" assertion.
- drugbank_resource:DB00661_DB00976 title "DDI between Verapamil and Telithromycin - Telithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vinblastine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Telithromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00976 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB00976 assertion.
- drugbank:DB00661 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00661_DB00976 assertion.